Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Cash from Investing Activities
Interpace Biosciences Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Cash from Investing Activities
-$1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
12%
|
|
DaVita Inc
NYSE:DVA
|
Cash from Investing Activities
-$771.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-21%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Investing Activities
-$20.9B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-28%
|
|
Cigna Corp
NYSE:CI
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Investing Activities
-$1.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
See Also
What is Interpace Biosciences Inc's Cash from Investing Activities?
Cash from Investing Activities
-1m
USD
Based on the financial report for Sep 30, 2023, Interpace Biosciences Inc's Cash from Investing Activities amounts to -1m USD.
What is Interpace Biosciences Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
12%
The average annual Cash from Investing Activities growth rates for Interpace Biosciences Inc have been 7% over the past three years , -22% over the past five years , and 12% over the past ten years .